MFS Blended Research Mid Cap Eq R3 holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
MFS Blended Research Mid Cap Equity Fund R3 BMSTX
- NAV / 1-Day Return 17.18 / +0.82 %
- Total Assets 3.2B
-
Adj. Expense Ratio
0.840%
- Expense Ratio 0.840%
- Distribution Fee Level Low
- Share Class Type Retirement, Medium
- Category Mid-Cap Blend
- Investment Style Mid Blend
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.38%
- Turnover 51%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 1:34 AM GMT+0
Morningstar’s Analysis BMSTX
Will BMSTX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 17.1
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Northern Trust Corp | 1.85 | 60M | Financial Services |
Ameriprise Financial Inc | 1.80 | 58M | Financial Services |
DexCom Inc | 1.75 | 57M | Healthcare |
Humana Inc | 1.72 | 56M | Healthcare |
Aramark | 1.69 | 55M | Industrials |
Valero Energy Corp | 1.68 | 54M | Energy |
Westinghouse Air Brake Technologies Corp | 1.67 | 54M | Industrials |
Okta Inc Class A | 1.66 | 54M | Technology |
Illumina Inc | 1.63 | 53M | Healthcare |
Popular Inc | 1.60 | 52M | Financial Services |